{"id":"https://openalex.org/W7203581663","doi":"https://doi.org/10.1016/j.ijpharm.2026.127317","title":"Theranostic silica nanoparticles for selective and simultaneous delivery of paclitaxel and coumarin to hypoxic tumors","display_name":"Theranostic silica nanoparticles for selective and simultaneous delivery of paclitaxel and coumarin to hypoxic tumors","publication_year":2026,"publication_date":"2026-08-16","ids":{"openalex":"https://openalex.org/W7203581663","doi":"https://doi.org/10.1016/j.ijpharm.2026.127317","pmid":"https://pubmed.ncbi.nlm.nih.gov/42604719"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2026.127317","doi":"https://doi.org/10.1016/j.ijpharm.2026.127317","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2026.127317","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.ijpharm.2026.127317","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5119472950","display_name":"Paula Rodrigo-Mart\u00ednez","orcid":"https://orcid.org/0009-0003-4797-7708","observed_orcids":["https://orcid.org/0009-0003-4797-7708"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210145258","display_name":"Institut des Biomol\u00e9cules Max Mousseron","ror":"https://ror.org/05d1e6v30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210128300","https://openalex.org/I4210145258"]},{"id":"https://openalex.org/I60053951","display_name":"Universitat Polit\u00e8cnica de Val\u00e8ncia","ror":"https://ror.org/01460j859","country_code":"ES","type":"education","lineage":["https://openalex.org/I60053951"]}],"countries":["ES","FR"],"is_corresponding":false,"raw_author_name":"Paula Rodrigo-Mart\u00ednez","raw_affiliation_strings":["Instituto Interuniversitario de Investigaci\u00f3n de Reconocimiento Molecular y Desarrollo Tecnol\u00f3gico (IDM), Universitat Polit\u00e8cnica de Val\u00e8ncia, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France"],"raw_orcid":"https://orcid.org/0009-0003-4797-7708","affiliations":[{"raw_affiliation_string":"Instituto Interuniversitario de Investigaci\u00f3n de Reconocimiento Molecular y Desarrollo Tecnol\u00f3gico (IDM), Universitat Polit\u00e8cnica de Val\u00e8ncia, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I16097986","https://openalex.org/I19894307","https://openalex.org/I4210145258","https://openalex.org/I60053951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059105769","display_name":"Lamiaa M. A. Ali","orcid":"https://orcid.org/0000-0003-1176-5335","observed_orcids":["https://orcid.org/0000-0003-1176-5335"]},"institutions":[{"id":"https://openalex.org/I11935315","display_name":"\u00c9cole Nationale Sup\u00e9rieure de Chimie de Montpellier","ror":"https://ror.org/03sgyqj04","country_code":"FR","type":"education","lineage":["https://openalex.org/I11935315","https://openalex.org/I19894307"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210145258","display_name":"Institut des Biomol\u00e9cules Max Mousseron","ror":"https://ror.org/05d1e6v30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210128300","https://openalex.org/I4210145258"]},{"id":"https://openalex.org/I84524832","display_name":"Alexandria University","ror":"https://ror.org/00mzz1w90","country_code":"EG","type":"education","lineage":["https://openalex.org/I84524832"]}],"countries":["EG","FR"],"is_corresponding":false,"raw_author_name":"Lamiaa Mohamed Ahmed Ali","raw_affiliation_strings":["Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France; Department of Biochemistry, Medical Research Institute, University of Alexandria, Alexandria 21561, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France; Department of Biochemistry, Medical Research Institute, University of Alexandria, Alexandria 21561, Egypt","institution_ids":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210145258","https://openalex.org/I84524832"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031161097","display_name":"Carmen Coll","orcid":"https://orcid.org/0000-0002-8401-7912","observed_orcids":["https://orcid.org/0000-0002-8401-7912"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I60053951","display_name":"Universitat Polit\u00e8cnica de Val\u00e8ncia","ror":"https://ror.org/01460j859","country_code":"ES","type":"education","lineage":["https://openalex.org/I60053951"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carmen Coll","raw_affiliation_strings":["Instituto Interuniversitario de Investigaci\u00f3n de Reconocimiento Molecular y Desarrollo Tecnol\u00f3gico (IDM), Universitat Polit\u00e8cnica de Val\u00e8ncia, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; Departamento de Qu\u00edmica Org\u00e1nica, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain"],"raw_orcid":"https://orcid.org/0000-0002-8401-7912","affiliations":[{"raw_affiliation_string":"Instituto Interuniversitario de Investigaci\u00f3n de Reconocimiento Molecular y Desarrollo Tecnol\u00f3gico (IDM), Universitat Polit\u00e8cnica de Val\u00e8ncia, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; Departamento de Qu\u00edmica Org\u00e1nica, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain","institution_ids":["https://openalex.org/I16097986","https://openalex.org/I60053951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065946860","display_name":"Magali Gary\u2010Bobo","orcid":"https://orcid.org/0000-0001-9641-212X","observed_orcids":["https://orcid.org/0000-0001-9641-212X"]},"institutions":[{"id":"https://openalex.org/I11935315","display_name":"\u00c9cole Nationale Sup\u00e9rieure de Chimie de Montpellier","ror":"https://ror.org/03sgyqj04","country_code":"FR","type":"education","lineage":["https://openalex.org/I11935315","https://openalex.org/I19894307"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210145258","display_name":"Institut des Biomol\u00e9cules Max Mousseron","ror":"https://ror.org/05d1e6v30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210128300","https://openalex.org/I4210145258"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Magali Gary-Bobo","raw_affiliation_strings":["Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France"],"raw_orcid":"https://orcid.org/0000-0001-9641-212X","affiliations":[{"raw_affiliation_string":"Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France","institution_ids":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210145258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106509821","display_name":"Jean\u2010Yves Winum","orcid":"https://orcid.org/0000-0003-3197-3414","observed_orcids":["https://orcid.org/0000-0003-3197-3414"]},"institutions":[{"id":"https://openalex.org/I11935315","display_name":"\u00c9cole Nationale Sup\u00e9rieure de Chimie de Montpellier","ror":"https://ror.org/03sgyqj04","country_code":"FR","type":"education","lineage":["https://openalex.org/I11935315","https://openalex.org/I19894307"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210145258","display_name":"Institut des Biomol\u00e9cules Max Mousseron","ror":"https://ror.org/05d1e6v30","country_code":"FR","type":"facility","lineage":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210128300","https://openalex.org/I4210145258"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean-Yves Winum","raw_affiliation_strings":["Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France. Electronic address: jean-yves.winum@umontpellier.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut des Biomol\u00e9cules Max Mousseron (IBMM), University of Montpellier, CNRS, ENSCM, Montpellier, France. Electronic address: jean-yves.winum@umontpellier.fr","institution_ids":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I19894307","https://openalex.org/I4210145258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000863427","display_name":"Pau Arroyo","orcid":"https://orcid.org/0000-0001-9290-3714","observed_orcids":["https://orcid.org/0000-0001-9290-3714"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I60053951","display_name":"Universitat Polit\u00e8cnica de Val\u00e8ncia","ror":"https://ror.org/01460j859","country_code":"ES","type":"education","lineage":["https://openalex.org/I60053951"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pau Arroyo","raw_affiliation_strings":["Instituto Interuniversitario de Investigaci\u00f3n de Reconocimiento Molecular y Desarrollo Tecnol\u00f3gico (IDM), Universitat Polit\u00e8cnica de Val\u00e8ncia, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; Departamento de Qu\u00edmica Org\u00e1nica, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain"],"raw_orcid":"https://orcid.org/0000-0001-9290-3714","affiliations":[{"raw_affiliation_string":"Instituto Interuniversitario de Investigaci\u00f3n de Reconocimiento Molecular y Desarrollo Tecnol\u00f3gico (IDM), Universitat Polit\u00e8cnica de Val\u00e8ncia, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; Departamento de Qu\u00edmica Org\u00e1nica, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain","institution_ids":["https://openalex.org/I16097986","https://openalex.org/I60053951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004773248","display_name":"Jose Antonio De Saja Saez","orcid":"https://orcid.org/0000-0002-7797-7077","observed_orcids":["https://orcid.org/0000-0002-7797-7077"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I60053951","display_name":"Universitat Polit\u00e8cnica de Val\u00e8ncia","ror":"https://ror.org/01460j859","country_code":"ES","type":"education","lineage":["https://openalex.org/I60053951"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose A. S\u00e1ez","raw_affiliation_strings":["Instituto Interuniversitario de Investigaci\u00f3n de Reconocimiento Molecular y Desarrollo Tecnol\u00f3gico (IDM), Universitat Polit\u00e8cnica de Val\u00e8ncia, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; Departamento de Qu\u00edmica Org\u00e1nica, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain"],"raw_orcid":"https://orcid.org/0000-0002-7797-7077","affiliations":[{"raw_affiliation_string":"Instituto Interuniversitario de Investigaci\u00f3n de Reconocimiento Molecular y Desarrollo Tecnol\u00f3gico (IDM), Universitat Polit\u00e8cnica de Val\u00e8ncia, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; Departamento de Qu\u00edmica Org\u00e1nica, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain","institution_ids":["https://openalex.org/I16097986","https://openalex.org/I60053951"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028736986","display_name":"Pablo Gavi\u00f1a","orcid":"https://orcid.org/0000-0002-8496-6448","observed_orcids":["https://orcid.org/0000-0002-8496-6448"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I4210105141","display_name":"Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine","ror":"https://ror.org/01gm5f004","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210105141"]},{"id":"https://openalex.org/I60053951","display_name":"Universitat Polit\u00e8cnica de Val\u00e8ncia","ror":"https://ror.org/01460j859","country_code":"ES","type":"education","lineage":["https://openalex.org/I60053951"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Pablo Gavi\u00f1a","raw_affiliation_strings":["Instituto Interuniversitario de Investigaci\u00f3n de Reconocimiento Molecular y Desarrollo Tecnol\u00f3gico (IDM), Universitat Polit\u00e8cnica de Val\u00e8ncia, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; Departamento de Qu\u00edmica Org\u00e1nica, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; CIBER de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain. Electronic address: pablo.gavina@uv.es"],"raw_orcid":"https://orcid.org/0000-0002-8496-6448","affiliations":[{"raw_affiliation_string":"Instituto Interuniversitario de Investigaci\u00f3n de Reconocimiento Molecular y Desarrollo Tecnol\u00f3gico (IDM), Universitat Polit\u00e8cnica de Val\u00e8ncia, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; Departamento de Qu\u00edmica Org\u00e1nica, Universitat de Val\u00e8ncia, Av. Vicente Andr\u00e9s Estell\u00e9s, 19, 46100 Burjassot, Valencia, Spain; CIBER de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain. Electronic address: pablo.gavina@uv.es","institution_ids":["https://openalex.org/I16097986","https://openalex.org/I4210105141","https://openalex.org/I60053951"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5028736986","https://openalex.org/A5106509821"],"corresponding_institution_ids":["https://openalex.org/I11935315","https://openalex.org/I1294671590","https://openalex.org/I16097986","https://openalex.org/I19894307","https://openalex.org/I4210105141","https://openalex.org/I4210145258","https://openalex.org/I60053951"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":{"value":4650,"currency":"USD","value_usd":4650},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.42068038,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"703","issue":null,"first_page":"127317","last_page":"127317"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.0568000003695488,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10735","display_name":"Mesoporous Materials and Catalysis","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/theranostic-nanoparticles","display_name":"theranostic nanoparticles","score":0.8379999995231628},{"id":"https://openalex.org/keywords/mesoporous-silica-nanoparticles","display_name":"mesoporous silica nanoparticles","score":0.9980000257492065},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8330000042915344},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.9700000286102295},{"id":"https://openalex.org/keywords/self-immolative-spacer","display_name":"self-immolative spacer","score":0.9200000166893005},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.48100000619888306},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.6150000095367432},{"id":"https://openalex.org/keywords/zebrafish-xenograft-model","display_name":"zebrafish xenograft","score":0.7960000038146973},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.33000001311302185},{"id":"https://openalex.org/keywords/real-time-drug-release-monitoring","display_name":"real-time drug release monitoring","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.8274000287055969},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7946000099182129},{"id":"https://openalex.org/C2781338262","wikidata":"https://www.wikidata.org/wiki/Q111812","display_name":"Coumarin","level":2,"score":0.7451000213623047},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.43529999256134033},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.43459999561309814},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42750000953674316},{"id":"https://openalex.org/C2984430287","wikidata":"https://www.wikidata.org/wiki/Q186249","display_name":"Pharmaceutical technology","level":2,"score":0.3741999864578247},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.3573000133037567},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3231000006198883},{"id":"https://openalex.org/C2983812674","wikidata":"https://www.wikidata.org/wiki/Q134808","display_name":"Delivery system","level":2,"score":0.29319998621940613},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.289000004529953},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.26499998569488525},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.26440000534057617},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2630000114440918},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2606000006198883}],"mesh":[{"descriptor_ui":"D000068936","descriptor_name":"Theranostic Nanomedicine","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D000072258","descriptor_name":"Tumor Hypoxia","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000072283","descriptor_name":"A549 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003374","descriptor_name":"Coumarins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003374","descriptor_name":"Coumarins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009601","descriptor_name":"Nitroreductases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012822","descriptor_name":"Silicon Dioxide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012822","descriptor_name":"Silicon Dioxide","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015027","descriptor_name":"Zebrafish","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D065546","descriptor_name":"Drug Liberation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ijpharm.2026.127317","doi":"https://doi.org/10.1016/j.ijpharm.2026.127317","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2026.127317","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:42604719","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42604719","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-05735765v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-05735765","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics, 2026, 703, pp.127317. ⟨10.1016/j.ijpharm.2026.127317⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.ijpharm.2026.127317","doi":"https://doi.org/10.1016/j.ijpharm.2026.127317","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2026.127317","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2944813750","display_name":null,"funder_award_id":"CIAICO/2022/146","funder_id":"https://openalex.org/F4320321864","funder_display_name":"Generalitat Valenciana"},{"id":"https://openalex.org/G5460031352","display_name":null,"funder_award_id":"11424","funder_id":"https://openalex.org/F4320307844","funder_display_name":"European Molecular Biology Organization"}],"funders":[{"id":"https://openalex.org/F4320307844","display_name":"European Molecular Biology Organization","ror":"https://ror.org/04wfr2810"},{"id":"https://openalex.org/F4320315062","display_name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","ror":null},{"id":"https://openalex.org/F4320321864","display_name":"Generalitat Valenciana","ror":"https://ror.org/0097mvx21"},{"id":"https://openalex.org/F4320335322","display_name":"European Regional Development Fund","ror":"https://ror.org/00k4n6c32"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1888148519","https://openalex.org/W1977369219","https://openalex.org/W2044647958","https://openalex.org/W2054253814","https://openalex.org/W2055870112","https://openalex.org/W2058559717","https://openalex.org/W2112645200","https://openalex.org/W2125257427","https://openalex.org/W2137634849","https://openalex.org/W2142504874","https://openalex.org/W2514937118","https://openalex.org/W2606150231","https://openalex.org/W2625747098","https://openalex.org/W2736361238","https://openalex.org/W2758199728","https://openalex.org/W2766316158","https://openalex.org/W2789637558","https://openalex.org/W2906405458","https://openalex.org/W2988773550","https://openalex.org/W3013037695","https://openalex.org/W3035335179","https://openalex.org/W3119636523","https://openalex.org/W3187419526","https://openalex.org/W4205145979","https://openalex.org/W4306942174","https://openalex.org/W4378418231","https://openalex.org/W4379879413","https://openalex.org/W4390603880","https://openalex.org/W4400130702","https://openalex.org/W4407510589"],"related_works":["https://openalex.org/W4407510589","https://openalex.org/W3002756899","https://openalex.org/W2794794116","https://openalex.org/W2131802255","https://openalex.org/W4401627116","https://openalex.org/W4212827228","https://openalex.org/W4413819354","https://openalex.org/W2606435743","https://openalex.org/W4400623374","https://openalex.org/W4405954272"],"abstract_inverted_index":{"Theranostic":[0],"nanomaterials,":[1],"that":[2,124],"combine":[3],"diagnostic":[4,190],"imaging":[5],"with":[6,66,143,171,192],"drug":[7,118],"delivery,":[8],"have":[9,40],"emerged":[10],"as":[11,185],"a":[12,54,67,71,77,95,154],"promising":[13],"alternative":[14],"to":[15,58,76,83,169],"conventional":[16],"oncology":[17],"therapy.":[18],"Tumor":[19],"hypoxia":[20],"and":[21,53,105,162],"the":[22,48,92,99,103,106,125,129,178],"poor":[23],"solubility":[24],"of":[25,51,102,108,117,131,180],"chemotherapeutics":[26],"like":[27],"paclitaxel":[28],"(PTX)":[29],"remain":[30],"critical":[31],"obstacles":[32],"in":[33,88,147,150,196],"oncology.":[34],"To":[35],"address":[36],"these":[37,181],"challenges,":[38],"we":[39],"developed":[41],"hypoxia-responsive":[42],"theranostic":[43,183],"mesoporous":[44],"silica":[45,62],"nanoparticles":[46],"for":[47,114],"selective":[49],"delivery":[50],"PTX":[52],"coumarin":[55,73,109],"fluorescent":[56],"dye":[57],"hypoxic":[59,89,137,197],"tumors.":[60],"The":[61],"nanocarrier":[63],"is":[64],"capped":[65],"molecular":[68],"gate":[69,93],"containing":[70],"masked":[72],"fluorophore":[74],"attached":[75],"nitro-containing":[78],"self-immolative":[79],"spacer.":[80],"Upon":[81],"exposure":[82],"nitroreductases":[84],"(NTR),":[85],"enzymes":[86],"overexpressed":[87],"tumor":[90,160,164],"microenvironments,":[91],"undergoes":[94],"self-immolation":[96],"reaction,":[97],"triggering":[98],"simultaneous":[100],"release":[101,195],"cargo":[104],"activation":[107],"fluorescence.":[110],"This":[111,175],"design":[112],"allows":[113],"real-time":[115],"monitoring":[116],"release.":[119],"In":[120],"vitro":[121],"assays":[122],"demonstrated":[123],"nanocarriers":[126,188],"selectively":[127],"reduced":[128,172],"viability":[130],"A549":[132],"lung":[133],"cancer":[134],"cells":[135],"under":[136],"conditions":[138],"while":[139],"exhibiting":[140],"high":[141],"biocompatibility":[142],"healthy":[144],"THP-1":[145],"macrophages":[146],"normoxia.":[148],"Moreover,":[149],"vivo":[151],"studies":[152],"using":[153],"zebrafish":[155],"xenograft":[156],"model":[157],"confirmed":[158],"effective":[159],"accumulation":[161],"significant":[163],"regression":[165],"(34%":[166],"reduction)":[167],"compared":[168],"controls,":[170],"systemic":[173],"toxicity.":[174],"proof-of-concept":[176],"establishes":[177],"potential":[179],"NTR-responsive":[182],"MSNs":[184],"versatile":[186],"multifunctional":[187],"integrating":[189],"tracking":[191],"targeted":[193],"therapeutic":[194],"environments.":[198]},"counts_by_year":[],"updated_date":"2026-10-25T09:29:13.331239","created_date":"2026-08-17T00:00:00"}